NCT06323655View on ClinicalTrials.gov

Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

August 28, 2018

Study Completion Date

August 28, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Tasimelteon

oral capsule

DRUG

Active Control Placebo

oral capsule

DRUG

Tasimelteon Placebo

oral capsule

DRUG

Active Control

oral capsule

Trial Locations (1)

Unknown

Vanda Investigational Site, Laval

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY